| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 11/25/2010 | US20100297114 Antigen presenting cell targeted vaccines |
| 11/25/2010 | US20100297111 Nanobodies against tumor necrosis factor-alpha |
| 11/25/2010 | US20100297110 Antibody specific for human il-4 for the treatment of cancer |
| 11/25/2010 | US20100297109 Methods for inhibiting fascin |
| 11/25/2010 | US20100297107 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 11/25/2010 | US20100297103 Antibody having enhanced adcc activity and method for production thereof |
| 11/25/2010 | US20100297101 Integrin alpha. II .B.beta.3 Specific Antibodies and Peptides |
| 11/25/2010 | US20100297083 Polynucleotides and Polypeptide of Human KV1.3, Compositions Comprising Same and Methods of Using Same |
| 11/25/2010 | US20100297070 COMPOSITIONS AND METHODS FOR AMELIORATING CNS INFLAMMATION, PSYCHOSIS, DELIRIUM, PTSD or PTSS |
| 11/25/2010 | US20100297061 Stat3 antagonists and their uses as vaccines against cancer |
| 11/25/2010 | US20100297060 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 11/25/2010 | US20100297013 Humanized antibody |
| 11/25/2010 | US20100297012 Humanized antibody |
| 11/25/2010 | US20100297011 Isolated peptides and uses thereof |
| 11/25/2010 | US20100297008 Ganglioside associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumors |
| 11/25/2010 | US20100297004 High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
| 11/25/2010 | US20100297003 Anti-human tenascin monoclonal antibody |
| 11/25/2010 | CA2762302A1 Compositions and methods for the therapy and diagnosis of influenza |
| 11/25/2010 | CA2761886A1 Antibodies or fragments thereof directed against a staphylococcus aureus epitope of isaa or isab |
| 11/24/2010 | EP2253707A2 Expec-specific proteins, genes encoding them and uses thereof |
| 11/24/2010 | EP2253646A1 Anti-dual integrin antibody and compositions and conjugates comprising said antibody |
| 11/24/2010 | EP2253644A1 Compositions and methods for producing a composition |
| 11/24/2010 | EP2253643A1 Novel compositions and methods in cancer associated with altered expression of PRLR |
| 11/24/2010 | EP2253642A1 Polypeptides, cDNAs encoding the same and utilization thereof |
| 11/24/2010 | EP2252897A2 Method for direct detection of ischaemia-modified albumin using a partner for binding to an aldehyde derivative resulting from the peroxidation of lipids in bound form |
| 11/24/2010 | EP2252633A1 Anti-trka antibodies and derivatives thereof |
| 11/24/2010 | EP2252632A1 Antibodies directed to angiopoietin-1 and angiopoietin-2 and use thereof |
| 11/24/2010 | EP2252631A2 Bcr-complex-specific antibodies and methods of using same |
| 11/24/2010 | EP2252319A2 Methods for modulating a population of myeloid-derived suppressor cells and uses thereof |
| 11/24/2010 | EP2252316A2 Modulation of adenoviral tropism |
| 11/24/2010 | EP1896849B1 Antibodies against histone modifications for clinical diagnosis and prognosis of cancer |
| 11/24/2010 | EP1780275B1 Polypeptide having a delta 5 fatty acid unsaturating activity, polynucleotide coding for the polypeptide and use thereof |
| 11/24/2010 | EP1551988B1 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 11/24/2010 | EP1355919B1 Molecules with extended half-lives, compositions and uses thereof |
| 11/24/2010 | EP1326896B1 Human anti-cd40 antibodies |
| 11/24/2010 | EP1119371B1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 11/24/2010 | EP0804572B1 Fusion protein comprising bpTK7 |
| 11/24/2010 | EP0444181B2 C-erbb-2 external domain: gp75 |
| 11/24/2010 | CN1958610B Medication of guiding antibody for anti leukaemia in monocarpotic cellularity |
| 11/24/2010 | CN101896504A Bivalent, bispecific antibodies |
| 11/24/2010 | CN101896503A Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof |
| 11/24/2010 | CN101896501A Antibody targeting osteoclast-related protein Siglec-15 |
| 11/24/2010 | CN101896500A Immune modulation via C-type lectin |
| 11/24/2010 | CN101896201A Method for treating bone fracture with anti-sclerostin antibodies |
| 11/24/2010 | CN101896200A Method of inhibition of leukemic stem cells |
| 11/24/2010 | CN101896199A Pharmaceutical formulation comprising hepatitis B virus neutralizing human antibody |
| 11/24/2010 | CN101896198A Ligands of HVEM for treating hematologic malignancies and autoimmune diseases |
| 11/24/2010 | CN101892251A Gene mutation and application of JAK2 exon 12 |
| 11/24/2010 | CN101892248A Monoclonal antibodies of avian influenza H5HA antigens |
| 11/24/2010 | CN101892240A Japanese blood fluke beta-catenin gene, protein and application |
| 11/24/2010 | CN101892239A Schistosoma japonicum katsurada Frizzled 9 gene, protein and use |
| 11/24/2010 | CN101892237A Polynucleotide related to mitochondrial membrane potential decrease and coded polypeptide and application thereof |
| 11/24/2010 | CN101892200A Anti-H3N8 subtype equine influenza virus monoclonal antibody and application thereof |
| 11/24/2010 | CN101892199A Method of detecting hepatitis c virus |
| 11/24/2010 | CN101892198A Anti-anthrax lethal factor chimeric monoclonal antibody, and preparation method and application thereof |
| 11/24/2010 | CN101891820A Humanized anti-human von willebrand disease factor monoclonal antibody and application thereof |
| 11/24/2010 | CN101891819A Single-chain antibody of broad-spectrum anti-p21ras protein and preparation method thereof |
| 11/24/2010 | CN101891818A Single-chain antibody in anti-human prostate-specific membrane antigen extracellular region and application thereof |
| 11/24/2010 | CN101891817A Monoclonal antibody capable of preventing high mobility group box-1 (HMGB-1) and application thereof |
| 11/24/2010 | CN101891816A Humanized monoclonal antibody IgG Fab fragment of dermatophagoides farinae 2 allergoid specificity as well as preparation method and application thereof |
| 11/24/2010 | CN101891815A CK19 monoclonal antibody, and preparation method and application thereof |
| 11/24/2010 | CN101891814A Anti-osteopontin OPN monoclonal antibody and application thereof |
| 11/24/2010 | CN101891806A Anti-flavivirus envelope E protein monoclonal antibody and application thereof |
| 11/24/2010 | CN101891805A Human enterovirus 71 type specific polypeptide and application thereof |
| 11/24/2010 | CN101890163A Use of anti-tnfalpha antibodies and another drug |
| 11/24/2010 | CN101028515B Anti-preisz bacterium and gingival carbon dioxide fibrophilic bacterium mixed IgY and its use in treating ozostomia and gingiva |
| 11/23/2010 | US7838648 Purified SR-p70 protein |
| 11/23/2010 | US7838645 Function of autophagy genes in cell death |
| 11/23/2010 | US7838639 antibody that specifically binds to a human TNF Receptor in the BRAIN (TRAIN) polypeptide; useful in regulating cell differentiation, death, and survival |
| 11/23/2010 | US7838638 Interleukin specific monoclonal antibody for use in treatment and prevention of autoimmune, cell proliferative, inflammatory and developmental disorders |
| 11/23/2010 | US7838637 Single-chain multiple antigen-binding molecule, its preparation and use |
| 11/23/2010 | US7838636 for diagnosing, treating, preventing and/or prognosing disorders related to these novel polypeptides; for genetic diseases such as muscular dystrophy and cystic fibrosis |
| 11/23/2010 | US7838635 CD16A binding proteins and use for the treatment of immune disorders |
| 11/23/2010 | US7838634 includes a high-through-put method of screening for a biomarker indicative of a disease, including the identification of a glycan alteration in a protein of a diseased patient |
| 11/23/2010 | US7838561 administering to mammal or higher vertebrate an effective amount of a pharmaceutical composition comprising N-[4-hydroxyphenyl]retinamide |
| 11/23/2010 | US7838489 tumor necrosis factor (TNF) receptors, immunoglobuin fusion proteins; anti-tumor necrosis factor antibodies; Crohn's disease, and acute and chronic immune diseases associated with transplantation |
| 11/23/2010 | US7838274 polynucleotides encoding the phospholipases; using these enzymes in industrial processes and methods of diagnosing fungal infections; Aspergillus niger; recombinant host cells wherein the expression of a phospholipase is significantly increased or wherein the activity of the phospholipase is increased |
| 11/23/2010 | US7838259 Genes of Porphyromonas gingivalis W83 involved in invasion of human cells |
| 11/23/2010 | US7838251 Nuclear matrix protein CC2 specfic immunoglobulin for use as evaluative tool in diagnosis of cell proliferative disorders of colon |
| 11/23/2010 | US7838248 anti-IL-18 Receptor accessory protein antibody; used in the study of cell signaling in response to IL-18 stimulation, and inducible protein expression systems based on the involvement of ACPL polypeptides in cell signaling |
| 11/23/2010 | US7838247 determination of the Alzheimer Related Membrane Protein (ARMP) gene on chromosome 14 and a related gene, E5-1, on chromosome 1; diagnosing Alzheimer's disease |
| 11/23/2010 | US7838244 staphylococcal exotoxin-like proteins (SETs); for identification and/or isolation of IgA and the scrum complement factor C5 |
| 11/23/2010 | US7838241 Genotyping methods using genomic sequence of the 5-lipoxygenase-activating protein (FLAP) and polymorphic markers thereof |
| 11/23/2010 | US7838041 autologously transplanting hematopoietic progenitor cell population which has been treated with antibody (monoclonal, chimeric, or humanized; not conjugated to toxin or cytolytic agent); radiotherapy |
| 11/23/2010 | US7838002 decrease inhibit or prevent viral propagation or screening of compounds impaction on the expression of shorter form core+1 protein; antiviral agents |
| 11/23/2010 | US7837998 Anti-cancer activity of an anti-thymidine kinase monoclonal antibody |
| 11/23/2010 | US7837996 treating or preventing HCV infection by administration of a vaccine composition comprising the monoclonal antibodies of the invention; exhibits immunological binding affinity for a hepatitis C virus (HCV) E1 antigen |
| 11/23/2010 | US7837995 Anticancer agents; low dosage; side effect reduction |
| 11/23/2010 | US7837993 Methods and compositions for regeneration of aged skeletal muscle tissues |
| 11/23/2010 | US7837980 conjugating drug to antibody by reducing antibody with reducing agent, treating antibody with reoxidizing agent to reform interchain disulfide bond of antibody to form partially reoxidized antibody such that two cysteine thiols remain, conjugating drug to interchain thiol of antibody via maleimide group |
| 11/23/2010 | CA2384355C Methods and means for modification of plant flowering characteristics |
| 11/23/2010 | CA2343655C Interleukin 17-like receptor protein |
| 11/23/2010 | CA2342200C Use of certain drugs for treating nerve root injury |
| 11/23/2010 | CA2158791C Dna sequences encoding the machado-joseph disease gene and uses thereof |
| 11/23/2010 | CA2132421C Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
| 11/18/2010 | WO2010132886A1 Compositions and methods relating to xmrv-related diseases and conditions |
| 11/18/2010 | WO2010132872A1 Combination therapies and methods using anti-cd3 modulating agents and anti-tnf antagonists |
| 11/18/2010 | WO2010132604A2 Neutralizing molecules to influenza viruses |
| 11/18/2010 | WO2010132532A1 B cell surface reactive antibodies |
| 11/18/2010 | WO2010132481A1 Human nt-pro b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms |